BioXcel Therapeutics, Inc (BTAI) insider trading
Every open-market stock purchase and sale by BioXcel Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $43.1K over the last 12 months (4 sales). No open-market buys.
- Last insider buy: Peter Mueller (Director), $14.5K, 7 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $43.1K (4 sales).
Recent BTAI insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 15, 2026 | Richard I Steinhart (CFO) | Bought (not open market) | — |
| Jun 15, 2026 | Vimal Mehta (CEO) | Bought (not open market) | — |
| Jun 15, 2026 | Frank Yocca (C-suite exec) | Bought (not open market) | — |
| Jun 15, 2026 | Javier Rodriguez (Officer) | Bought (not open market) | — |
| May 20, 2026 | Vimal Mehta (CEO) | Sold | $21.1K |
| May 20, 2026 | Richard I Steinhart (CFO) | Sold | $7.4K |
| May 20, 2026 | Frank Yocca (C-suite exec) | Sold | $7.4K |
| May 20, 2026 | Javier Rodriguez (Officer) | Sold | $7.1K |
| May 4, 2026 | Richard I Steinhart (CFO) | Bought (not open market) | — |
| May 4, 2026 | Frank Yocca (C-suite exec) | Bought (not open market) | — |
| May 4, 2026 | Javier Rodriguez (Officer) | Bought (not open market) | — |
| May 4, 2026 | Vimal Mehta (CEO) | Bought (not open market) | — |
| May 1, 2026 | Javier Rodriguez (Officer) | Bought (not open market) | — |
| May 1, 2026 | Vimal Mehta (CEO) | Bought (not open market) | — |
| May 1, 2026 | Frank Yocca (C-suite exec) | Bought (not open market) | — |
| May 1, 2026 | Richard I Steinhart (CFO) | Bought (not open market) | — |
| Mar 15, 2026 | Frank Yocca (C-suite exec) | Bought (not open market) | — |
| Mar 15, 2026 | Richard I Steinhart (CFO) | Bought (not open market) | — |
| Mar 15, 2026 | Javier Rodriguez (Officer) | Bought (not open market) | — |
| Mar 15, 2026 | Vimal Mehta (CEO) | Bought (not open market) | — |
| Mar 14, 2026 | Vimal Mehta (CEO) | Bought (not open market) | — |
| Mar 14, 2026 | Javier Rodriguez (Officer) | Bought (not open market) | — |
| Mar 14, 2026 | Frank Yocca (C-suite exec) | Bought (not open market) | — |
| Mar 14, 2026 | Richard I Steinhart (CFO) | Bought (not open market) | — |
| Jan 9, 2026 | Michal Votruba (Director) | Bought (not open market) | — |
Who's trading BTAI
- Vimal Mehta, CEO: sold $21.1K (1 sale), last Jun 15, 2026
- Javier Rodriguez, Officer: sold $7.1K (1 sale), last Jun 15, 2026
- Richard I Steinhart, CFO: sold $7.4K (1 sale), last Jun 15, 2026
- Frank Yocca, C-suite exec: sold $7.4K (1 sale), last Jun 15, 2026
- Peter Mueller, Director: other filings, last Jan 9, 2026
- Rajiv Patni, Director: other filings, last Jan 9, 2026
- Michal Votruba, Director: other filings, last Jan 9, 2026
- June Bray, Director: other filings, last Jan 9, 2026
- Sandeep Laumas, Director: other filings, last Jan 9, 2026
- David J. Mack, Director: other filings, last Jan 9, 2026
- Michael Patrick Miller, Director: other filings, last Jan 9, 2026
Get free alerts when an insider at BioXcel Therapeutics, Inc files a new trade →